Solvay SA

Solvay's capital structure is characterized by a high debt-to-equity ratio of 2.13, indicating a significant reliance on debt financing. The company's liquidity position is moderate, with a current ratio of 1.17 and free cash flow of -126 million EUR, suggesting limited capacity to meet short-term obligations without external financing. The negative free cash flow is primarily driven by capital expenditures of 220 million EUR, which outpaced operating cash flow of 682 million EUR. In terms of profitability, Solvay's return on equity (ROE) of 2.94% and return on assets (ROA) of 0.49% are below the industry median for Diversified Chemicals, indicating subpar performance relative to its peers. The company's operating income of 269 million EUR and net income of 30 million EUR reflect a narrow margin, with a gross profit of 1.003 billion EUR. These figures suggest that Solvay is struggling to convert its revenue into sustainable profits. Solvay's revenue is not segmented by geographic region in the available data, but the company's exposure to global markets is evident given its classification as a Diversified Chemicals firm. The lack of geographic segmentation makes it difficult to assess the company's concentration risk, but the global nature of the chemical industry implies that Solvay is subject to macroeconomic and geopolitical fluctuations. The company's growth trajectory is mixed. While revenue for the latest period was 4.746 billion EUR, the outlook for the current fiscal year is uncertain due to the negative free cash flow and high debt load. Analysts have provided a mean price target of 24.94 EUR and a median price target of 26.00 EUR, with a mean recommendation of 3.31, indicating a cautious outlook. The company's capital expenditures suggest a commitment to maintaining and expanding its production capabilities, but the negative free cash flow may limit its ability to fund these investments internally. Solvay's risk profile is moderate, with a liquidity risk rating of medium and a dilution risk rating of low. The company's net cash position is negative after subtracting total debt, which could constrain its financial flexibility. However, the low dilution risk suggests that the company is not currently issuing shares at a rate that would significantly dilute existing shareholders. Recent events, including analyst estimates and price targets, indicate a mixed sentiment among investors. The mean recommendation of 3.31 suggests a neutral to slightly bearish outlook, with seven "hold" ratings and only two "buy" ratings. The wide range of price targets, from 18.00 EUR to 32.00 EUR, reflects uncertainty about the company's future performance and valuation.